Detection of serum collagen type IV in children with type 1 (insulin-dependent) diabetes mellitus - A longitudinal study

Pediatric Diabetes

Volumn 2, Issue 4, 2001, Pages 184-190

  Nicoloff, G ^a   Baydanoff, S ^a   Stanimirova, N ^a   Petrova, Ch ^a   Christova, P ^a  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

Collagen type IV derived peptides; Diabetic microvascular complications; ELISA

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CAPTOPRIL; COLLAGEN TYPE 4; MEMBRANE PROTEIN;

ADOLESCENT; AGE; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MALE; MICROALBUMINURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; SCHOOL CHILD; SEX DIFFERENCE;

EID: 0035695494     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5448.2001.20408.x     Document Type: Article

References (44)

1. Basement membrane proteins: Structure, assembly, and cellular interactions
2. Basement membrane (Type IV) collagen
3. Molecules of the extracellular matrix: Potential role of collagens and glycoproteins in intestinal adaptation
4. A network model for organization of type IV collagen molecules in basement membranes
5. Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose
6. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulphate proteoglycan and laminin
7. Early byosynthetic changes in diabetic-like retinopathy of galactose-fed rats
8. Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation
9. Extracellular matrix in human diabetic nephropathy: Reduced expression of heparan sulphate in skin basement membrane
10. Analysis of extracellular matrix proteins in biological fluids
11. Normi za arterialno naliagane spored rasta I telesnata masa pri deca ot grad Sofia
12. Determination of anti-AGE antibodies in human serum
13. Biochemical and biophysical alterations of the 7S and NC1 domain of collagen type IV from human diabetic kidneys
14. Reduced collagenolytic activity of rat kidneys with streptozotocin diabetes
15. The effect of non-enzymatic glucosylation on the binding of the main non-collagenous NC1 domain to type IV collagen
16. Glycation products and the pathogenesis of diabetic complications
17. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression
18. Transforming growth factor beta in diabetic nephropathy
19. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator
20. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
21. Transforming growth factor-beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans
22. Transforming factor beta modulates the expression of collagenase and metalloproteinase inhibitor
23. Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase
24. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by novel advanced glycation end products inhibitor, OPB-9195
25. Basement membrane related protein antigens in blood
26. Etude de la fibronectine et ducollagene de type IV plasmatiques chez le diabetique
27. Basement membrane components (7S collagen, laminin P1) are increased in sera of diabetics and activate platelets in vitro
28. Concentration of 7S collagen and laminin P1 in sera of patients with diabetes mellitus
29. Difference of serum levels of type IV collagen 7S between early or overt nephropathy and nondiabetic renal disease in diabetic patients with micro- or macroalbuminuria
30. Serum type III, IV collagens and TIMP in patients with type II diabetes mellitus
31. Serum concentrations of intact type IV collagen in diabetics
32. Serum levels of laminin P1 and type IV collagen in healthy children and juvenile diabetics
33. Urine and serum levels of the carboxyterminal domain (NCl) of collagen IV in membranous glomerulonephritis and diabetic nephropathy
34. Serum levels of laminin P1 and type IV collagen in healthy children and children with insulin-dependent diabetes mellitus
35. Western blotting of NC1 type IV collagen fragments in human plasma
36. Urinary type IV collagen as a marker for diabetic nephropathy
37. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM. Comparison with urinary albumin and markers of tubular dysfunction and/or damage
38. Serum type IV collagen and prolyl hydroxylase levels: Effect of gender and age
39. Increased glomerular filtration rate as a predictor of diabetic nephropathy - An 8-year prospective study
40. Relationship between early metabolic control and the development of microalbuminuria - A longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus
41. Nonenzymatic glycosylation: Role in the pathogenesis of diabetic complications
42. Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus
43. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty
44. Diabetes mellitus, dyslipoproteinaemias and atherosclerosis